Fundamental Analysis of Mink Therapeutics Inc - Growth / Value Index


INKT - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 5.00
   Book Value in last 3 years is trending down
   Book value is negative
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -0.0023 -1.40 -49.20 %
Price to Book -0.0267 -1.92 97.07 % -0.0083
Price to Sales -0.0030 0 0 %
Enterprise Value to EBITDA Multiple -0.0010 -1.27 -431.76 %


INKT - Profitability Highlights

Profitability Analysis

   Strong Return On Capital Employed of 137.18
   Company Earning excess return
   During the past twelve months, the company has given a strong Net Margin of 129.24%
   All key Trailing Twelve Months Margin growing by 15 %
   Tsr Profitability Index - Poor Score of 32.14
   Piotroski F Score - Very Poor Value of 1.0
   Very Low Dividend Yield of 0 %
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 0 0 0 % 0
Return On Asset -285.63 -544.10 -317.37 % -55.31
Net Profit Margin 129.24 0 0 % 0
Operating Profit Margin 263.06 0 0 % 0
EBITDA Margin 263.06 0 0 % 0


Highlights
Market Cap35051.04 K
Enterprise Value31683.81 K
Price/Book TTM-0.0267
Outstanding Share34704.00 K
Float/ Outstanding Share28.87%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score1.00
Altman Z Score-60.12
Sloan Ratio-1.67
Peter Lynch Fair Value0


INKT - Growth Highlights

Growth Analysis

   Tsr Growth Index - Very Poor Score of 5.00
   Annual sales in last 3 years is trending down
   Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue -11708.19 M 100.00 % 100.00 %
Gross Profit -15396.87 M 100.01 % 7148996 %
EBITDA -30799.08 M 11.38 % 140539 %
Net Profit -15131.98 M 11.51 % 69753.36 %
EPS -438.27 32.98 % NA


INKT - Stability Highlights

Stability Analysis

   Tsr Stability Index - Good Score of 75.00
   Altman Z Score of -60.12 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of 0
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 0 0 % -0.207
Cash Ratio 0.295 -80.93 %
Quick Ratio 0 0 % 0.540
Shareholders Equity -396.62 -21121.27 %
Debt to EBITDA 0 0 %


Historical Valuation Ratios of Mink Therapeutics Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Mink Therapeutics Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Mink Therapeutics Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Mink Therapeutics Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)